Instil Bio (TIL)
Biotechnology developer seeking therapeutic candidates through acquisitions and in-licensing.
$7.78
At close+0.09 (+1.17%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions31 holders · as of Mar 31, 2026 · largest filers plus last quarter's tail | ≈ 33.88% | 2.30M shares | |
| Otherremainder | ≈ 66.12% | 4.48M shares |
6.78M company shares as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
Institutions13F, as of Mar 31, 2026
31 holders · 2.30M shares · 10 new positions · 14 increased · 8 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BML Capital Management, LLC | 645.6K | 9.52% | 0 | May 6, 2026 |
| CPMG Inc | 410.9K | 6.06% | 0 | May 15, 2026 |
| Vivo Capital, LLC | 292.7K | 4.32% | 0 | May 20, 2026 |
| Kalehua Capital Management LLC | 183.0K | 2.70% | +183.0Knew | May 15, 2026 |
| Vanguard Capital Management LLC | 174.6K | 2.57% | +174.6Knew | May 15, 2026 |
| Millennium Management LLC | 132.9K | 1.96% | −109.8K | May 15, 2026 |
| Renaissance Technologies LLC | 59.1K | 0.87% | −8.7K | May 14, 2026 |
| BlackRock, Inc. | 52.0K | 0.77% | +805 | May 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| BML Investment Partners, L.P. | 9.50% | 645.6K | 13G | Feb 9, 2026 ↗ |
| Perceptive Advisors LLCincl. Joseph Edelman, Perceptive Life Sciences Master Fund, Ltd. | 5.30% | 345.5K | 13G | Sep 27, 2024 ↗ |
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 10, 2025 | Sandeep Laumasofficer: CFO and CBO | Sale · 2 lots | 30,000 | $23.39 | 0 |
CongressHouse and Senate disclosures
Not reported.